Showing results (1351-1360 of 1,615) with videos related to
Sort By:
Pageof 162
European Journal of Pharmacology|February 11, 2014
Effects of anatabine and unilateral maximal eccentric isokinetic muscle actions on serum markers of muscle damage and inflammationNathaniel D M Jenkins, Terry J Housh, Kristen C Cochrane, et al.Journal of Pharmaceutical Sciences|November 14, 2018
Fifty-Eight Years and Counting: High-Impact Publishing in Computational Pharmaceutical Sciences and Mechanism-Based ModelingGregory E Amidon, Bradley D Anderson, Joseph P Balthasar, et al.Circulation Research|August 27, 2020
High-Density Lipoprotein Carries Markers That Track With Recovery From StrokeDeanna L Plubell, Alex M Fenton, Sara Rosario, et al.The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 24, 2025
Mito-Modulatory Medication Use and Skeletal Muscle Bioenergetics Among Older Men and Women: The Study of Muscle, Mobility, and AgingHoward J Phang, Jaclyn Bergstrom, Rabia S Atayee, et al.Hypertension (Dallas, Tex. : 1979)|May 1, 2013
Prevalence and risk factors for hypertension in hemophiliaAnnette von Drygalski, Nicholas A Kolaitis, Ricki Bettencourt, et al.Physiological Measurement|September 12, 2013
An examination of neuromuscular and metabolic fatigue thresholdsHaley C Bergstrom, Terry J Housh, Kristen C Cochrane, et al.Therapeutic Innovation & Regulatory Science|September 19, 2018
Medicines Adaptive Pathways to Patients (MAPPs): A Story of International Collaboration Leading to ImplementationDuane Schulthess, Lynn G Baird, Mark Trusheim, et al.Research Square|June 12, 2025
Tobacco smoke carcinogens exacerbate APOBEC mutagenesis and carcinogenesisReuben Harris, Erik Bergstrom, Marcos Díaz-Gay, et al.Arthritis and Rheumatism|June 10, 2004
Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonistsLaurie Bergstrom, David E Yocum, Neil M Ampel, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|September 10, 2008
Topical ketorolac in vitreoretinal surgery: a prospective, randomized, placebo-controlled, double-masked trialStephen J Kim, Wayne R Lo, G Baker Hubbard, et al.Pageof 162